Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

19.110
-0.460-2.35%
Volume:4.21M
Turnover:80.20M
Market Cap:19.63B
PE:-21.97
High:19.610
Open:19.180
Low:18.600
Close:19.570
52wk High:38.640
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:1.04
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-13.49%
ROA:-3.70%
PB:2.85
PE(LYR):-21.97
PS:6.17

Loading ...

Junshi Biosciences licenses anti-IL-17A antibody “Roconkibart” to Fosun Wanbang in RMB1.34 billion deal for Greater China

Bulletin Express
·
Jul 01

Shanghai Junshi Biosciences - Will Grant Fosun Wanbang Right to Develop, Others, Roconkibart ("js005") in Greater China Region

THOMSON REUTERS
·
Jul 01

Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI

Dow Jones
·
Jun 29

Junshi Bio appoints Chen Liang as Independent Non-Executive Director; committee leadership realigned

Bulletin Express
·
Jun 26

JUNSHI BIO Appoints Chen Liang as Independent Non-Executive Director

Stock News
·
Jun 26

Junshi Bio Updates Board Composition and Committee Leadership

Bulletin Express
·
Jun 26

JUNSHI BIO Shares Surge Over 5% Following Strategic Investment in Shanghai Biopharma Firm for ADC and Multispecific Antibody Development

Stock News
·
Jun 12

Hong Kong Stocks Decline Amid Tech Selloff; Shanghai Junshi Biosciences Slips on Oncology Venture

MT Newswires Live
·
Jun 08

Junshi Biosciences Takes Stake in Oncology JV via Asset Contribution

MT Newswires Live
·
Jun 08

JUNSHI BIO Tables AGM Agenda: No 2025 Dividend, Up to RMB8.50 Billion Credit, RMB5.00 Billion Guarantee Quota and Fresh Mandates for Debt and Share Issuance

Bulletin Express
·
Jun 05

Junshi Bio issues proxy form for 2025 AGM; agenda covers profit distribution, financing mandates and INED election

Bulletin Express
·
Jun 05

Junshi BIO to Contribute Patent Equipment Valued at RMB 53.08 Million for Stake in Shanghai Zhiyu Biopharma, Expanding into ADC and Multi-Specific Antibody R&D

Stock News
·
Jun 05

Junshi Bio Reorganises R&D Vehicle Junyan Hongshi; Controlled VC Arm Injects RMB0.10 Billion for 9.09% Stake

Bulletin Express
·
Jun 05

Junshi Bio to Close H-Share Register 23–26 June 2026 Ahead of 2025 AGM

Bulletin Express
·
Jun 05

Shanghai Junshi Biosciences - Approved Proposal on Change in Shareholding Structure of Implementing Entity of Some Sub-Projects

THOMSON REUTERS
·
Jun 05

Shanghai Junshi Biosciences - Junyan Hongshi Intends to Increase Its Registered Capital by RMB100 Mln

THOMSON REUTERS
·
Jun 05

Junshi Biosciences Updates Board Composition and Committee Structure

Bulletin Express
·
Jun 05

JUNSHI BIO Announces 2025 Annual General Meeting Scheduled for June 26, 2026

Deep News
·
Jun 05

Junshi Bio Maintains Stable Share Base in May; 13.21 Million H-Share Options Outstanding

Bulletin Express
·
Jun 03

AH Share Premium and Deviation Rankings as of June 1st

Stock News
·
Jun 01